Cost implications of different policies for the treatment of arteriovenous malformations of the brain
Cost implications of different policies for the treatment of arteriovenous malformations of the brain
复制标题
治疗脑动静脉畸形的不同政策的成本影响
DOI：
--
复制
发表时间：
1991
期刊：
影响因子：
--
通讯作者：
J. Lamb
中科院分区：
文献类型：
--
作者：
M. Nelson;G. Bonsor;J. Lamb
脑动静脉畸形（AVM）可通过常规手术、伽玛刀或直线加速器放射外科手术和栓塞治疗。从联合王国的中心获得了这些治疗费用的估计数，并用于计算治疗脑动静脉畸形的三项政策的费用。接近目前临床实践的政策相对具有成本效益。对于单次治疗，栓塞的成本低于其他疗法。使用术前栓塞增加了30-40%的政策成本，当用作唯一治疗时，多次治疗使栓塞成为最昂贵的治疗。需要对脑AVM栓塞治疗进行详细的成本效益分析。
Arteriovenous malformations (AVMs) of the brain may be treated with conventional surgery, gamma-knife or linear accelerator radiosurgery and embolisation. Estimates for the costs of these treatments have been obtained from centres in the United Kingdom and have been used to calculate the costs of three policies for treating brain AVMs. Policies that approximate to present clinical practice are relatively cost-effective. For a single treatment session embolisation costs less than other therapies. Used preoperatively embolisation adds 30–40% to policy costs and when used as the only therapy multiple treatment sessions make embolisation the most costly therapy. Detailed cost-benefit analysis is required for embolisation in the treatment of brain AVMs.